Associated Papers
Loss of mitochondrial amidoxime-reducing component 1 (mARC1) prevents disease progression by reducing fibrosis in multiple mouse models of chronic liver disease.
Coyne ES et al.
Hepatology Communications, 2025
Biochemical and functional characterization of the p.A165T missense variant of mitochondrial amidoxime-reducing component 1.
Hou W et al.
The Journal of Biological Chemistry, 2024
mARC1 in MASLD: Modulation of lipid accumulation in human hepatocytes and adipocytes.
Jones AK et al.
Hepatology Communications, 2024
Select a paper to view details